Burzynski Research Institute, Inc. (BZYR) is a Delaware-incorporated clinical-stage company engaged in research, production, and development of Antineoplastons—growth-inhibiting peptides, amino acid derivatives, and organic acids—for cancer treatment. The company conducts Phase II clinical trials of Antineoplaston formulations A10 and AS2-1, holds FDA orphan drug designation for brain stem glioma and gliomas, and has not generated significant operating revenue since inception.
Q2 FY2026 — expected 2026-07-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-05-20 | 2025-02-28 | 0001558370-25-008021 | EDGAR | 33K words |
| 2024-05-29 | 2024-02-29 | 0001558370-24-008731 | EDGAR | 33K words |
| 2023-05-25 | 2023-02-28 | 0001558370-23-010476 | EDGAR | 33K words |
| 2022-05-26 | 2022-02-28 | 0001558370-22-009398 | EDGAR | — |
| 2021-05-24 | 2021-02-28 | 0001104659-21-071200 | EDGAR | — |
| 2020-05-28 | 2020-02-29 | 0001104659-20-067054 | EDGAR | — |
| 2019-05-29 | 2019-02-28 | 0001104659-19-032421 | EDGAR | — |
| 2018-05-22 | 2018-02-28 | 0001104659-18-035071 | EDGAR | — |
| 2017-05-11 | 2017-02-28 | 0001104659-17-031953 | EDGAR | — |
| 2016-06-13 | 2016-02-29 | 0001104659-16-126875 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-01-13 | 2025-11-30 | 0001104659-26-003337 | EDGAR | 11K words |
| 2025-10-14 | 2025-08-31 | 0001104659-25-099284 | EDGAR | 11K words |
| 2025-07-15 | 2025-05-31 | 0001558370-25-009242 | EDGAR | 7K words |
| 2025-01-13 | 2024-11-30 | 0001558370-25-000165 | EDGAR | 9K words |
| 2024-10-10 | 2024-08-31 | 0001558370-24-013239 | EDGAR | 8K words |
| 2024-07-15 | 2024-05-31 | 0001558370-24-009817 | EDGAR | 7K words |
| 2024-01-16 | 2023-11-30 | 0001558370-24-000294 | EDGAR | 9K words |
| 2023-10-12 | 2023-08-31 | 0001558370-23-016401 | EDGAR | 8K words |
| 2023-07-13 | 2023-05-31 | 0001558370-23-011866 | EDGAR | 8K words |
| 2023-01-13 | 2022-11-30 | 0001558370-23-000269 | EDGAR | 9K words |
| 2022-10-13 | 2022-08-31 | 0001558370-22-014980 | EDGAR | — |
| 2022-07-14 | 2022-05-31 | 0001558370-22-010716 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2025-07-24 | 0001104659-25-070376 | EDGAR | 1K words |
| 2023-05-22 | 0001104659-23-063151 | EDGAR | 1K words |
| 2023-04-06 | 0001104659-23-042811 | EDGAR | 1K words |
| 2021-10-06 | 0001104659-21-123645 | EDGAR | — |
| 2013-07-08 | 0001104659-13-053518 | EDGAR | — |
| 2012-07-06 | 0001104659-12-047927 | EDGAR | — |
| 2012-03-01 | 0001104659-12-014985 | EDGAR | — |
| 2011-09-12 | 0001104659-11-051249 | EDGAR | — |
| 2009-05-22 | 0001104659-09-034645 | EDGAR | — |
| 2006-01-24 | 0000950129-06-000545 | EDGAR | — |
87 total filings indexed. 55 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000724445 |
| Ticker | BZYR |
| Exchange | OTC |
| SIC | 2835: In Vitro & In Vivo Diagnostic Substances |
| Incorporated | DE |
| Headquarters | Houston, Texas |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/BZYR (~200 tokens, structured JSON with cryptographic provenance)